Notably, the sensitivities of VCA-IgA and EA-IgA in this study were higher than those reported in the meta-analysis, further confirming the reliability and potential advantages of these biomarkers in the diagnosis of NPC. Here, CD79A is linked to nasopharyngeal carcinoma.